Syensqo has secured a major milestone in aerospace materials innovation with the FAA-sponsored NCAMP qualification of its PRISM EP2400 epoxy resin system, used with Teijin Carbon s Tenax IMS65 E23 24K Non-Crimp Fabrics (NCF) and woven unidirectional reinforcements.

The qualification, recognized by both the FAA and EASA under NMS 241 (material specification) and NPS 82401 (process specification), makes PRISM EP2400 the first resin infusion system to be included in the NCAMP database. The accompanying publicly available NCAMP Material Property Data Report now provides aerospace manufacturers with certified, design-ready data, a breakthrough that accelerates the adoption of resin infusion technologies in both commercial and defense programs.

Until now, NCAMP allowables have primarily focused on prepreg systems, leaving a significant data gap for out-of-autoclave (OoA) resin infusion processes. With this qualification, OEMs now have access to a validated, scalable alternative to traditional autoclave methods, particularly for integrated primary and secondary structures where resin infusion offers performance, cost, and scalability advantages.

Key benefits of PRISM EP2400:

• Low viscosity enabling robust and repeatable resin transfer processing
• Damage-tolerant, toughened epoxy for high-performance applications
• Long, stable pot life suited to large or complex structural infusions
• One-part, low-reactivity system, optimized for safe global transport

Advantages of NCAMP qualification:

• Faster adoption certified property data eliminates the need for duplicate testing
• Lower cost significantly reduced qualification expenses
• Reduced program risk OEMs can move directly into certification stages

By closing the resin infusion data gap in NCAMP, PRISM EP2400 enables faster, safer, and more cost-efficient adoption of high-performance infusion processes in aerospace structures, said Rob Blackburn, Head of Customer Engineering at Syensqo.

With this qualification, Syensqo positions itself at the forefront of resin infusion innovation, offering OEMs a viable, certified alternative to prepreg and autoclave-based composite manufacturing.

Source: www.syensqo.com